| Model Number |
168210 |
| Medical Device Problem Codes |
Delivered as Unsterile Product (1421); Unsealed Device Packaging (1444); Packaging Problem (3007)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
E1: complainant state: (b)(6) complainant country:(b)(6) name of affiliation: (b)(6) based on the available information, this event is deemed to be a reportable malfunction.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number reporting site: 1049092 manufacturing site: 1000317571.
|
| |
|
Event or Problem Description
|
|
It was reported that the product was sealed with the primary package which caused an open seal at the side of pack.The product was not used by the patient.The photographs depicting the issue were received from the complainant.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information - this emdr is being submitted to include the below: h6: investigation results under imdrf cause investigation code, imdrf investigation findings, imdrf cause conclusions.H10: investigation summary: a batch record review was completed and it was identified that pad miscuts had been seen during the batch production, for which a tech was required on line.All seal strength tests completed throughout the batch manufacture were satisfactory.Kaltostat drs 5x5cm wt (1x10pk) ster int was manufactured under sap code (b)(4) and manufacturing lot number 2c02168 on 23 mar 2022.Lot # 2c02168 was sterilized under run id 2173-27199a and released on review of results of sterilization provided by sterilization company steris.All of the results were within specification and products were released.No nonconformity was identified during the manufacturing process of lot 2c02168.This is the only complaint for the affected lot registered within database.Two photographs were received for this issue and have been evaluated in accordance with work instructions (wi).The photographs confirm the expected lot number, product and the complaint issue where a single dressing was found trapped in the seal.A corrective action / preventive actions (capa) was not raised for this complaint as a capa for a similar issue is currently open, for which this batch is within bounding.This product was manufactured on doyen 2, but has since been validated for production on doyen 3.It is therefore not possible to investigate this issue specifically as it is no longer produced on the doyen 2 line.As the other capa record was open for a dressing in seal issue for a batch produced on doyen 3, no further investigation is necessary for this issue as investigation and corrections will be found within tw 1688796 for the other batch.Previous to this recent capa, 3 other nonconformance's (ncs) have also covered open seal and dressing in seal issues.This issue will be monitored through the post market product monitoring review process, standard operating procedure (sop).To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number: reporting site: 1049092.Manufacturing site: 1000317571.
|
| |
|
Event or Problem Description
|
|
To date no additional patient or event details have been received.
|
| |
|
Search Alerts/Recalls
|